Pietra C - Search Results

1

Anticonvulsant preclinical profile of CHF 3381: dopaminergic and glutamatergic mechanisms.

Gandolfi O, Bonfante V, Voltattorni M, Dall'Olio R, Poli A, Pietra C, Villetti G. Gandolfi O, et al. Among authors: pietra c. Pharmacol Biochem Behav. 2001 Sep;70(1):157-66. doi: 10.1016/s0091-3057(01)00591-3. Pharmacol Biochem Behav. 2001. PMID: 11566153

2

Mechanisms of action of CHF3381 in the forebrain.

Barbieri M, Bregola G, Buzzi A, Marino S, Zucchini S, Stables JP, Bergamaschi M, Pietra C, Villetti G, Simonato M. Barbieri M, et al. Among authors: pietra c. Br J Pharmacol. 2003 Aug;139(7):1333-41. doi: 10.1038/sj.bjp.0705381. Br J Pharmacol. 2003. PMID: 12890713 Free PMC article.

3

Preclinical evaluation of CHF3381 as a novel antiepileptic agent.

Villetti G, Bregola G, Bassani F, Bergamaschi M, Rondelli I, Pietra C, Simonato M. Villetti G, et al. Among authors: pietra c. Neuropharmacology. 2001 Jun;40(7):866-78. doi: 10.1016/s0028-3908(01)00026-0. Neuropharmacology. 2001. PMID: 11378157

4

Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.

Zucchini S, Buzzi A, Bergamaschi M, Pietra C, Villetti G, Simonato M. Zucchini S, et al. Among authors: pietra c. Neuroreport. 2002 Nov 15;13(16):2071-4. doi: 10.1097/00001756-200211150-00016. Neuroreport. 2002. PMID: 12438928

5

Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.

Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Maiorino M, Pietra C, Rondelli I, Chamiot-Clerc P, Simonato M, Barbieri M. Villetti G, et al. Among authors: pietra c. J Pharmacol Exp Ther. 2003 Aug;306(2):804-14. doi: 10.1124/jpet.103.050039. Epub 2003 May 15. J Pharmacol Exp Ther. 2003. PMID: 12750440

6

Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Trabace L, Cassano T, Steardo L, Pietra C, Villetti G, Kendrick KM, Cuomo V. Trabace L, et al. Among authors: pietra c. J Pharmacol Exp Ther. 2000 Jul;294(1):187-94. J Pharmacol Exp Ther. 2000. PMID: 10871311

7

Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells.

Mazzucchelli M, Porrello E, Villetti G, Pietra C, Govoni S, Racchi M. Mazzucchelli M, et al. Among authors: pietra c. J Neural Transm (Vienna). 2003 Aug;110(8):935-47. doi: 10.1007/s00702-003-0006-x. J Neural Transm (Vienna). 2003. PMID: 12898348

8

4-Aminopyridine derivatives with antiamnesic activity.

Andreani A, Leoni A, Locatelli A, Morigi R, Rambaldi M, Pietra C, Villetti G. Andreani A, et al. Among authors: pietra c. Eur J Med Chem. 2000 Jan;35(1):77-82. doi: 10.1016/s0223-5234(00)00103-3. Eur J Med Chem. 2000. PMID: 10733605

9

Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice.

Capsoni S, Giannotta S, Stebel M, Garcia AA, De Rosa R, Villetti G, Imbimbo BP, Pietra C, Cattaneo A. Capsoni S, et al. Among authors: pietra c. Am J Alzheimers Dis Other Demen. 2004 May-Jun;19(3):153-60. doi: 10.1177/153331750401900303. Am J Alzheimers Dis Other Demen. 2004. PMID: 15214201 Free PMC article.

10

Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder.

Palea S, Pietra C, Trist DG, Artibani W, Calpista A, Corsi M. Palea S, et al. Among authors: pietra c. Br J Pharmacol. 1995 Jan;114(1):35-40. doi: 10.1111/j.1476-5381.1995.tb14902.x. Br J Pharmacol. 1995. PMID: 7712025 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page